Who Paid My Doc
James Adametz
Neurological Surgery North Little Rock, AR Medical Doctor
NPI 1437129244 CMS profile 109712
5201 Northshore Dr, Suite 100, North Little Rock, AR 72118
General payments
$6,341
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, James Adametz of North Little Rock, AR is reported in the CMS Open Payments database as having received $6,341 across 68 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 62nd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $248 | 6 | |
| 2024 | General | $3,419 | 24 | |
| 2023 | General | $630 | 8 | |
| 2022 | General | $1,009 | 14 | |
| 2021 | General | $524 | 8 | |
| 2020 | General | $282 | 4 | |
| 2019 | General | $228 | 4 |
Beside peers
- James Adametz
- Neurological Surgery median
- Middle half of Neurological Surgery
- National median
In program year 2025, general payments to James Adametz were reported at $248. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.
Show as a table
| Year | James Adametz | Neurological Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $228 | $582 | $138–$3,006 | $163 |
| 2020 | $282 | $294 | $76–$2,174 | $114 |
| 2021 | $524 | $387 | $105–$2,432 | $132 |
| 2022 | $1,009 | $542 | $139–$2,989 | $149 |
| 2023 | $630 | $534 | $145–$2,697 | $160 |
| 2024 | $3,419 | $574 | $155–$3,046 | $164 |
| 2025 | $248 | $596 | $159–$3,102 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 11 drugsPart D claims
747
Drug cost
$5,121
Branded share of claims
12.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Tizanidine Hcl | Generic | 286 | $1,470 | |
| Gabapentin | Generic | 82 | $790 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 92 | $761 | |
| Methylprednisolone | Generic | 77 | $673 | |
| Diclofenac Sodium | Generic | 45 | $552 | |
| Naproxen | Generic | 33 | $334 | |
| Cyclobenzaprine Hcl | Generic | 17 | $188 | |
| Meloxicam | Generic | 42 | $114 | |
| Tramadol Hcl | Generic | 43 | $98 | |
| Cephalexin | Generic | 15 | $77 |
The 10 drugs with the highest cost, of 11 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 55 billing codesPaid by Medicare
$110,824
Medicare patients
257
Services billed
2,708
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Ischemic heart disease | 40% | |
| Diabetes | 35% | |
| Depression | 28% | |
| Chronic kidney disease | 20% | |
| COPD | 19% | |
| Atrial fibrillation | 17% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 | Office | 57 | 125 | $684 |
| Injection, bupivicaine, not otherwise specified, 0.5 mg J0665 | Office | 28 | 1,890 | $18 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
68 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurological Surgery in Arkansas
Erika Petersen
Neurological Surgery · Little Rock, AR
James Blankenship
Neurological Surgery · Fayetteville, AR
Keith Norvill
Neurological Surgery · Hot Springs, AR
Muhammad Kandel
Neurological Surgery · Hot Springs, AR
John Day
Neurological Surgery · Little Rock, AR
Dominic Maggio
Neurological Surgery · Little Rock, AR
Related records
Neurological Surgery in Arkansas
Practitioners in the same specialty and state, ranked by reported value.
All Neurological Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Arkansas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.